top space
bottom spacer
  • Painless, rapid, precise skin permeation technology
  • Needle-free continuous glucose monitoring device
  • Needle-free, transdermal drug delivery

Icon   Echo Therapeutics in the News

More >>
05/11/2012 - Echo Therapeutics Announces First Quarter 20... PHILADELPHIA, May 11, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECT...

05/08/2012 - Echo Therapeutics Symphony® tCGM System To ... PHILADELPHIA, May 8, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasd...

Needle-Free Monitoring and Drug Delivery

Echo is developing its Prelude® SkinPrep System to allow for painless and significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction. Utilizing this technology, Echo is also developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for use in hospital critical care units and for people with diabetes.

Watch how easy it is to use the Symphony tCGM System